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 A low serum concentration of high-density lipoprotein (HDL) is a major risk factor 
for cardiovascular diseases (CVD). In several epidemiologic studies, a positive 
correlation between HDL concentration and selenium, an essential trace element, has 
been observed. Thus, selenium supplementation may increase HDL concentration and may be 
beneficial for preventing CVD. The aim of present study was to analyze the effects of 
selenium supplementation on the expression of preβ-HDL (nascent HDL) formation in 
human primary hepatocytes (Hc cells). We assumed healthy human taking selenium 
supplementation, and conducted experiments using non-malignant cells under a basal 
state condition (without stimulation) to evaluate the effects of selenium in human 
liver in healthy conditions in in vitro system. The Hc cells were cultured in a medium 
supplemented with 0-10 µM of sodium selenite. After 72-hour of incubation with sodium 
selenite, the 50% inhibitory concentration (IC
50
) was at 5 µM, and the activity of 
Glutathione peroxidase-1 (GPx-1) reached saturation at 50 nM. Next, the effects of 
sodium selenite supplementation (0, 25, 50, 100, 200 nM) on several target proteins and 
genes related to preβ-HDL formation were measured by western blot analysis and real-
time PCR, respectively. Protein expressions of GPx-1 and apolipoprotein A-I (apoA-I) 
were upregulated when treated with 50 nM of sodium selenite. These results were 
confirmed by increased mRNA expressions of these two genes. However, treatments with 
higher levels of sodium selenite (100 and 200 nM) reduced the effect. In contrast, the 
expression levels of other preβ-HDL formation-related proteins and mRNA, 
apolipoprotein A-II (apoA-II) and ATP-binding cassette transporter-1 (ABCA-1), were not 
significantly affected at any concentrations of sodium sel 
enite we tested.  
These results suggest that sodium selenite supplementation might play a role in 
preβ-HDL formation in Hc cells under basal state at low doses but not at high doses. 
Thus, an appropriate dose of selenium supplementation is essential for achieving the 
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とを想定し、健常人の肝臓におけるセレンの効果を in vitro で検討するため、非癌細胞を用い生
理学的条件下で実験を行った。亜セレン酸ナトリウム 0-10 µM 添加下において Hc 細胞を培養した
ところ、培養開始後 72 時間での 50%抑制濃度（IC
50
）は 5 µM であり、グルタチオンペルオキシダ
ーゼ-1(GPx-1)活性は 50 nM で飽和した。次に、亜セレン酸ナトリウム 0, 25, 50, 100, 200 nM 
添加下で preβ-HDL 形成に関連するタンパク質および遺伝子の発現をウエスタンブロットおよび
real-time PCR によって測定した。亜セレン酸ナトリウム濃度 50 nM において GPx-1 と
apolipoprotein A-I (apoA-I)のタンパク質、mRNA 発現ともに有意な増加が認められたが、それ以
上の濃度では効果が減少した。一方、他の preβ-HDL 形成関連タンパク質である apolipoprotein 
A-II (apoA-II)や ATP binding cassette transporter-1 (ABCA-1)の発現は亜セレン酸ナトリウム
による有意な増加は見られなかった。 
これらの結果から、低濃度の亜セレン酸ナトリウム補充は Hc 細胞における preβ-HDL 形成に関
与していることが示された。よって、健常者における CVD 予防への治療的利用には、適正濃度のセ
レン補充が必須であると考えられる。 
 
 
 
 
 
 
 
 
 
 
 
 
 
